Nicotine Improves Working Memory Span Capacity in Rats Following Sub-Chronic Ketamine Exposure

[1]  Valerie M. Beck,et al.  Reduced capacity but spared precision and maintenance of working memory representations in schizophrenia. , 2010, Archives of general psychiatry.

[2]  S. Wonnacott,et al.  Subtype-selective nicotinic agonists enhance olfactory working memory in normal rats: A novel use of the odour span task , 2010, Neuroscience Letters.

[3]  J. Buccafusco,et al.  A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. , 2009, Biochemical pharmacology.

[4]  F. Joseph McClernon,et al.  Effects of nicotine on novelty detection and memory recognition performance: double-blind, placebo-controlled studies of smokers and nonsmokers , 2009, Psychopharmacology.

[5]  M. Gutiérrez,et al.  Cognitive performance and cigarette smoking in first-episode psychosis , 2009, European Archives of Psychiatry and Clinical Neuroscience.

[6]  A. Hannan,et al.  Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation. , 2009, The international journal of neuropsychopharmacology.

[7]  Giuseppe Atzori,et al.  Efficacy of a Nicotine (4 mg)-Containing Lozenge on the Cognitive Impairment of Nicotine Withdrawal , 2008, Journal of clinical psychopharmacology.

[8]  J. Gold,et al.  Initial phase 2 trial of a nicotinic agonist in schizophrenia. , 2008, The American journal of psychiatry.

[9]  M. Jung,et al.  Prefrontal cortex and hippocampus subserve different components of working memory in rats. , 2008, Learning & memory.

[10]  D. Goff,et al.  The Effects of Transdermal Nicotine on Cognition in Nonsmokers with Schizophrenia and Nonpsychiatric Controls , 2008, Neuropsychopharmacology.

[11]  M. Carli,et al.  Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC , 2008, Psychopharmacology.

[12]  L. Bidzan.  [A review of the effects of nicotine on schizophrenia]. , 2007, Psychiatria polska.

[13]  S. Mosolov,et al.  Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial , 2007, Nature Medicine.

[14]  K. Perry,et al.  In vivo pharmacological characterization of the structurally novel, potent, selective mGlu2/3 receptor agonist LY404039 in animal models of psychiatric disorders , 2007, Psychopharmacology.

[15]  J. Kelly,et al.  The odour span task: A novel paradigm for assessing working memory in mice , 2007, Neuropharmacology.

[16]  J. Kelly,et al.  Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice , 2007, European Neuropsychopharmacology.

[17]  T. Nabeshima,et al.  Animal Model of Schizophrenia , 2006, Annals of the New York Academy of Sciences.

[18]  E. Levin,et al.  Ventral hippocampal α7 and α4β2 nicotinic receptor blockade and clozapine effects on memory in female rats , 2006, Psychopharmacology.

[19]  G. Reynolds,et al.  The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm , 2006, Behavioural Brain Research.

[20]  Robert C. Smith,et al.  Effects of Nicotine Nasal Spray on Cognitive Function in Schizophrenia , 2006, Neuropsychopharmacology.

[21]  E. Levin,et al.  Effects of clozapine on memory function in the rat neonatal hippocampal lesion model of schizophrenia , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  F. Joseph McClernon,et al.  Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization , 2006, Psychopharmacology.

[23]  A. Lahti,et al.  The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers , 2005, Psychopharmacology.

[24]  A. Belger,et al.  Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function. , 2005, Archives of general psychiatry.

[25]  T. Robbins,et al.  Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates , 2004, Neuroscience & Biobehavioral Reviews.

[26]  P. Skudlarski,et al.  Nicotine effects on brain function and functional connectivity in schizophrenia , 2004, Biological Psychiatry.

[27]  P. Newhouse,et al.  Effects of nicotinic stimulation on cognitive performance. , 2004, Current opinion in pharmacology.

[28]  H. Schroeder,et al.  Ketamine-induced changes in rat behaviour: A possible animal model of schizophrenia , 2003, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[29]  E. Levin,et al.  Nicotine Interactions with Haloperidol, Clozapine and Risperidone and Working Memory Function in Rats , 2002, Neuropsychopharmacology.

[30]  Robert C. Smith,et al.  Effects of Cigarette Smoking and Nicotine Nasal Spray on Psychiatric Symptoms and Cognition In Schizophrenia , 2002, Neuropsychopharmacology.

[31]  J. B. Murray,et al.  Phencyclidine (PCP): A Dangerous Drug, but Useful in Schizophrenia Research , 2002, The Journal of psychology.

[32]  Alan C. Evans,et al.  Working Memory in Another Dimension: Functional Imaging of Human Olfactory Working Memory , 2001, NeuroImage.

[33]  M. Sarter,et al.  Cortical cholinergic inputs mediate processing capacity: effects of 192 IgG‐saporin‐induced lesions on olfactory span performance , 2000, The European journal of neuroscience.

[34]  H. Eichenbaum,et al.  Neurotoxic Hippocampal Lesions Have No Effect on Odor Span and Little Effect on Odor Recognition Memory But Produce Significant Impairments on Spatial Span, Recognition, and Alternation , 2000, The Journal of Neuroscience.

[35]  D. Javitt.  Treatment of negative and cognitive symptoms , 1999, Current psychiatry reports.

[36]  Tamara Hershey,et al.  Ketamine-Induced NMDA Receptor Hypofunction as a Model of Memory Impairment and Psychosis , 1999, Neuropsychopharmacology.

[37]  E. Levin,et al.  Nicotine–Dizocilpine Interactions and Working and Reference Memory Performance of Rats in the Radial-Arm Maze , 1998, Pharmacology Biochemistry and Behavior.

[38]  Anil K Malhotra,et al.  Ketamine-Induced Exacerbation of Psychotic Symptoms and Cognitive Impairment in Neuroleptic-Free Schizophrenics , 1997, Neuropsychopharmacology.

[39]  D. Weinberger,et al.  Cognitive function in schizophrenia , 1997, International clinical psychopharmacology.

[40]  E D Levin,et al.  Acute nicotine interactions with nicotinic and muscarinic antagonists: working and reference memory effects in the 16-arm radial maze. , 1997, Behavioural pharmacology.

[41]  R. Roth,et al.  Clozapine Reverses the Spatial Working Memory Deficits Induced by FG7142 in Monkeys , 1997, Neuropsychopharmacology.

[42]  Bita Moghaddam,et al.  Activation of Glutamatergic Neurotransmission by Ketamine: A Novel Step in the Pathway from NMDA Receptor Blockade to Dopaminergic and Cognitive Disruptions Associated with the Prefrontal Cortex , 1997, The Journal of Neuroscience.

[43]  Jonathan Foulds,et al.  Cognitive performance effects of subcutaneous nicotine in smokers and never-smokers , 1996, Psychopharmacology.

[44]  E. Levin,et al.  Chronic nicotine working and reference memory effects in the 16-arm radial maze: interactions with D1 agonist and antagonist drugs , 1996, Psychopharmacology.

[45]  Herbert Weingartner,et al.  NMDA Receptor Function and Human Cognition: The Effects of Ketamine in Healthy Volunteers , 1996, Neuropsychopharmacology.

[46]  Bita Moghaddam,et al.  Characterization of Excitatory Amino Acid Modulation of Dopamine Release in the Prefrontal Cortex of Conscious Rats , 1996, Journal of neurochemistry.

[47]  B. Moghaddam,et al.  NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  J. Changeux,et al.  Nicotinic and muscarinic receptors in the rat prefrontal cortex: Differential roles in working memory, response selection and effortful processing , 1995, Psychopharmacology.

[49]  J. Krystal,et al.  Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. , 1994, Archives of general psychiatry.

[50]  Serge Laroche,et al.  Long-term potentiation in the prefrontal cortex following stimulation of the hippocampal CA1/subicular region , 1990, Neuroscience Letters.

[51]  James V. Hinrichs,et al.  Ketamine: behavioral effects of subanesthetic doses. , 1984, Journal of clinical psychopharmacology.

[52]  D. Lodge,et al.  The dissociative anaesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N‐methyl‐aspartate , 1983, British journal of pharmacology.

[53]  G. Rosenbaum,et al.  Study of a new schizophrenomimetic drug; sernyl. , 1959, A.M.A. archives of neurology and psychiatry.

[54]  木下 清二郎.  Effects of rat medial prefrontal cortex lesions on olfactory serial reversal and delayed alternation tasks , 2008 .

[55]  J. Suvisaari,et al.  Lifetime prevalence of psychotic and bipolar I disorders in a general population. , 2007, Archives of general psychiatry.

[56]  E. Levin,et al.  Nicotinic-antipsychotic drug interactions and cognitive function. , 2006, EXS.

[57]  Edward D. Levin,et al.  Nicotinic systems and cognitive function , 2005, Psychopharmacology.

[58]  Michael F. Green,et al.  A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia. , 2005, Schizophrenia bulletin.

[59]  B. Wexler,et al.  Effects of Smoking Abstinence on Visuospatial Working Memory Function in Schizophrenia , 2002, Neuropsychopharmacology.

[60]  S Laroche,et al.  Plasticity at hippocampal to prefrontal cortex synapses: Dual roles in working memory and consolidation , 2000, Hippocampus.

[61]  H. Groenewegen,et al.  The prefrontal cortex and the integration of sensory, limbic and autonomic information. , 2000, Progress in brain research.

[62]  R. Rosenheck,et al.  Impact of clozapine on negative symptoms and on the deficit syndrome in refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. , 1999, The American journal of psychiatry.

[63]  H. Meltzer,et al.  The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. , 1999, Schizophrenia bulletin.